Showing results (231-240 of 404) with videos related to

Sort By:
Pageof 41
Cardiovascular Diabetology|January 21, 2011
Temporal trends in the initiation of glucose-lowering medications after a first-time myocardial infarction - a nationwide study between 1997 and 2006Mette L Norgaard, Charlotte Andersson, Peter Riis Hansen, et al.
Journal of the American College of Cardiology|January 22, 2011
Calcium-channel blockers do not alter the clinical efficacy of clopidogrel after myocardial infarction: a nationwide cohort studyJonas B Olesen, Gunnar H Gislason, Mette G Charlot, et al.
European Heart Journal|August 16, 2011
Psoriasis and risk of atrial fibrillation and ischaemic stroke: a Danish Nationwide Cohort StudyOle Ahlehoff, Gunnar H Gislason, Casper H Jørgensen, et al.
JAMA Network Open|January 16, 2019
Prestroke and Poststroke Antithrombotic Therapy in Patients With Atrial Fibrillation: Results From a Nationwide CohortAnna Gundlund, Ying Xian, Eric D Peterson, et al.
Europace : European Pacing, Arrhythmias, and Cardiac Electrophysiology : Journal of the Working Groups on Cardiac Pacing, Arrhythmias, and Cardiac Cellular Electrophysiology of the European Society of Cardiology|May 16, 2009
Antiarrhythmic therapy and risk of death in patients with atrial fibrillation: a nationwide studySøren Skøtt Andersen, Morten Lock Hansen, Gunnar H Gislason, et al.
Journal of Internal Medicine|December 1, 2010
Psoriasis is associated with clinically significant cardiovascular risk: a Danish nationwide cohort studyO Ahlehoff, G H Gislason, M Charlot, et al.
Clinical Rheumatology|July 30, 2022
Long-term risk of adverse cardiovascular outcomes associated with cutaneous lupus erythematosus: a nationwide cohort studyAbdulrahman N Shams-Eldin, Adelina Yafasova, Mikkel Faurschou, et al.
European Heart Journal|January 10, 2006
Long-term compliance with beta-blockers, angiotensin-converting enzyme inhibitors, and statins after acute myocardial infarctionGunnar H Gislason, Jeppe N Rasmussen, Steen Z Abildstrøm, et al.
Europace : European Pacing, Arrhythmias, and Cardiac Electrophysiology : Journal of the Working Groups on Cardiac Pacing, Arrhythmias, and Cardiac Cellular Electrophysiology of the European Society of Cardiology|May 22, 2015
Risk of gastrointestinal adverse effects of dabigatran compared with warfarin among patients with atrial fibrillation: a nationwide cohort studyLaila Staerk, Gunnar H Gislason, Gregory Y H Lip, et al.
Pageof 41